We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $2.8M invested in Tonix Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
24.98% less ownership
Funds ownership: 46.25% → 21.27% (-25%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $6.62M
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $116K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$116K
Net Calls
-$116K
Net Calls Change
-$21K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$3.2M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.59M |
| 3 |
Broadfin Capital
New York
|
-$863K |
| 4 |
Pura Vida Investments
New York
|
-$567K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$169K |